Delivery Order SPE2DB20D2104-SPE2DB24FU11C
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,159,118 units of the pharmaceutical product Pulmozyme 1 mg/ml ampul 2.5 ml. The contract has a ceiling value of $15,650.51 and an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor and does not have any major subcontractors identified. This delivery order contract...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract worth $77,882.80 to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product, with a completion date of August 18, 2022. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) has awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pulmozyme 1 mg/mL ampul 2.5 mL. The $2,410.99 firm fixed-price contract has a completion date of March 22, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA for a wide range of pharmaceutical products and medical supplies to support the Department of Defense worldwide. This...
- The U.S. government awarded a $20,963.60 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, which has no set-aside designation, is for the provision of Pulmozyme 1 mg/ml ampul 2.5 ml to the Department of Defense (DoD) and its Medical Supply Chain agency. Amerisourcebergen, a major pharmaceutical distributor, holds significant Indefinite Delivery Contracts (IDCs) with the Defense Logistics Agency (DLA) Troop Support Medical for up to...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $11,864.81 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Pulmozyme 1 mg/mL ampules. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of...
- This federal contract award, valued at $5,736.05, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the prescription drug Pulmozyme (1 mg/ml ampul, 2.5 ml) and has a completion date of May 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $9,644.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of PULMOZYME 1 MG/ML AMPUL 2.5ML. The delivery order has a completion date of February 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award, which does not have a set-aside designation. The company also holds an indefinite delivery contract with DLA worth up to...
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is for the delivery of the pharmaceutical product Pulmozyme 1 mg/ml ampul 2.5ml to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $8,462.13, has an ultimate completion date of April 15, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply PULMOZYME 1 MG/ML AMPUL 2.5ML, a pharmaceutical product. The contract has a potential value of $2,410.99 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. Amerisourcebergen Drug Corp also holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pulmozyme 1 mg/ml ampul 2.5 ml. The contract is a Delivery Order with a Firm Fixed Price of $25,335.45 and a period of performance through November 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FU11CDelivery Order
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $3,264.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,558,409 units of the prescription medication Pulmozyme 1 mg/ml ampul 2.5ml. The contract has an ultimate completion date of May 10, 2024. Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, leverages its parent company's extensive supply chain to fulfill government contracts, primarily for the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025, as well as a smaller IDC with the Department of Justice Federal Bureau of Investigation valued up to $750,000 through May 2024. These contracts enable the government agencies to efficiently procure essential pharmaceutical products and medical supplies. This particular contract award was made on a full and open competition basis without any set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 5/9/24 |